Fabrication of paclitaxel nanocrystals by femtosecond laser ablation and fragmentation

Journal of Pharmaceutical Sciences

Volumn 100, Issue 3, 2011, Pages 1022-1030

  Kenth, Sukhdeep ^a   Sylvestre, Jean Philippe ^b   Fuhrmann, Kathrin ^c   Meunier, Michel ^b   Leroux, Jean Christophe ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^c ETH ZURICH   (Switzerland)

Author keywords

Cancer; Femtosecond laser; Nanoparticles; Nanotechnology; Paclitaxel; Particle size; Physicochemical; Preclinical development; Preformulation

Indexed keywords

NANOCRYSTAL; PACLITAXEL;

ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DEGRADATION; DRUG FORMULATION; F EMTOSECOND LASER ABLATION; FRAGMENTATION REACTION; INFRARED SPECTROSCOPY; LASER SURGERY; LOW LEVEL LASER THERAPY; NANOFABRICATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSPENSION; X RAY DIFFRACTION;

EID: 79251540576     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22335     Document Type: Article

References (26)

1. Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785-796.
2. Muller RH, Jacobs C, Kayser O. 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3-19.
3. Merisko-Liversidge E, Liversidge GG, Cooper ER. 2003. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 18:113-120.
4. Keck CM, Muller RH. 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 62:3-16.
5. Besner S, Kabashin A, Winnik F, Meunier M. 2008. Ultrafast laser based "green" synthesis of non-toxic nanoparticles in aqueous solutions. Appl Phys A: Mater Sci Process 93:955-959.
6. Asahi T, Sugiyama T, Masuhara H. 2008. Laser fabrication and spectroscopy of organic nanoparticles. Acc Chem Res 41:1790-1798.
7. Nagare S, Senna M. 2004. Reagglomeration mechanism of drug nanoparticles by pulsed laser deposition. Solid State Ionics 172:243-247.
8. Sylvestre JP, Kabashin AV, Sacher E, Meunier M. 2005. Femtosecond laser ablation of gold in water: Influence of the laser-produced plasma on the nanoparticle size distribution. Appl Phys A: Mater Sci Process 80:753-758.
9. Tamaki Y, Asahi T, Masuhara H. 2002. Nanoparticle formation of vanadyl phthalocyanine by laser ablation of its crystalline powder in a poor solvent. J Phys Chem A 106:2135-2139.
10. Hobley JN, Kajimoto T, Kasuya S, Hatanaka M, Fukumura K, Nishio H. 2007. Formation of 3, 4, 9, 10-perylenetetracarboxylicdianhydride nanoparticles with perylene and polyyne byproducts by 355 nm nanosecond pulsed laser ablation of microcrystal suspensions. J Photochem Photobiol A: Chem 189:105-113.
11. Besner S, Kabashin AV, Meunier M. 2007. Two-step femtosecond laser ablation-based method for the synthesis of stable and ultra-pure gold nanoparticles in water. Appl Phys A: Mater Sci Process 88:269-272.
12. Masuhara H, Sugiyama T, Asahi T. 2004. Formation of 10 nm-sized oxo(phtalocyaninato)vanadium(IV) particles by femtosecond laser ablation in water. Chem Lett 33:724-725.
13. Dordunoo SK, Burt HM. 1996. Solubility and stability of taxol: Effects of buffers and cyclodextrins. Int J Pharm 133:191-201.
14. Singla AK, Garg A, Aggarwal D. 2002. Paclitaxel and its formulations. Int J Pharm 235:179-192.
15. Miele E, Tomao F, Tomao S. 2009. Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer. Int J Nanomed 4:99-105.
16. Muller RH, Keck CM. 2004. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113:151-170.
17. Müller RH, Böhm BHL. 1998. Nanosuspensions. In Emulsions and nanosuspensions for the formulation of poorly soluble drugs; Müller RH, Benita S, Böhm B, Eds. Stuttgart, Germany: Medpharm Scientific, pp 149-173.
18. Pyo S-H, Cho JS, Choi HJ, Han BH. 2007. Preparation and dissolution profiles of the amorphous, dihydrated crystalline, and anhydrous crystalline forms of paclitaxel. Dry Technol 25:1759-1767.
19. Liggins RT, Hunter WL, Burt HM. 1997. Solid-state characterization of paclitaxel. J Pharm Sci 86:1458-1463.
20. Gi U-SM, Bumcham L, Jin-Hyun K. 2004. Preparation and characterization of paclitaxel from plant cell culture. Korean J Chem Eng 21:816-820.
21. 60 aqueous nanocolloids. J Photochem Photobiol A 207:7-12.
22. Jiaher T, Valentino JS. 2008. Degradation of paclitaxel and related compounds in aqueous solutions I: Epimerization. J Pharm Sci 97:1224-1235.
23. Jiaher T, Valentino JS. 2009. Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics. J Pharm Sci 99: 1288-1298.
24. Van Eerdenbrugh B, Van Den Mooter G, Augustijns P. 2008. Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64-75.
25. Van Eerdenbrugh BS, Froyen B, Van Humbeeck L, Martens J, Augustijns J, Van Den Mooter P. 2009. Downscaling drug nanosuspension production: Processing aspects and physicochemical characterization. AAPS PharmSciTech 10:44-53.
26. Sylvestre JP, Kenth S, Lueling K, Meunier M, Leroux JC. 2009. Fabrication of dispersed megestrol acetate nanocrystals by laser fragmentation in water. In 2009 AAPS Annual Meeting and Exposition, Los Angeles, California.